Why Many Global Drugs Never Reach Japan Press Coverage Why Many Global Drugs Never Reach Japan Despite faster reviews, many global drugs never reach Japan. Learn how early development decisions, trial…CertaraFebruary 5, 2026
Pharmacokinetic and toxicological evaluation of AB-CHMINACA in rodents: A comprehensive study Publication Pharmacokinetic and toxicological evaluation of AB-CHMINACA in rodents: A comprehensive study Explore how rodent study reveals 14 h half-life, key metabolites, and dose-dependent toxicity of AB-CHMINACA…CertaraFebruary 5, 2026
Trial designs: Non-inferiority vs. superiority vs. equivalence BlogKnowledge Base Trial designs: Non-inferiority vs. superiority vs. equivalence Understand superiority, non-inferiority, and equivalence trials, how their hypotheses differ, and how trial design impacts…Matt Zierhut, PhD MBAFebruary 3, 2026
Phoenix Roadshow 2026 – Florence Live Events Phoenix Roadshow 2026 – Florence CertaraFebruary 2, 2026
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants Publication Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…CertaraFebruary 2, 2026
Pharmacokinetics of colistin in adult critically ill patients in South Africa Publication Pharmacokinetics of colistin in adult critically ill patients in South Africa Discover how colistin PK comparable to other populations; AUC correlates with WCC and eGFR using…CertaraFebruary 2, 2026
Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®) On-Demand Webinar Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®) Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…CertaraJanuary 30, 2026
Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration Publication Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration See how oral hemp extract yields higher CBD exposure and unexpected THC-positive urine tests; topical…CertaraJanuary 29, 2026
Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®) On-Demand Webinar Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®) This on demand session demonstrates how Phoenix WinNonlin® and other tools work together within Phoenix®…CertaraJanuary 27, 2026
How model-informed drug development (MIDD) strengthens drug asset valuation and answers the questions investors care about most Blog How model-informed drug development (MIDD) strengthens drug asset valuation and answers the questions investors care about most Learn how Model-Informed Drug Development strengthens drug asset valuation by reducing uncertainty, predicting clinical performance,…CertaraJanuary 26, 2026